CA-AERA-TECHNOLOGY
24.9.2020 14:02:16 CEST | Business Wire | Press release
Aera Technology today announced the general availability of the Aera Cognitive Operating System™, the world's first cloud platform for Cognitive Automation . In extending availability beyond current customers and partners, including Merck, RB, and Unilever, Aera meets the growing need of companies whose operations have been impacted by changing or uncertain market conditions.
“We’ve worked with the world's largest organizations and complex supply chains to demonstrate the value of Cognitive Automation at scale. This tight collaboration has enabled us to build the Aera Cognitive Operating System™, which is now easy to implement and scale, and therefore available to an even wider range of companies,” said Frederic Laluyaux, CEO of Aera Technology.
Alessandro de Luca, CIO of Healthcare, Merck Group, noted, “We are all running on much shorter cycles in this dynamic world, and it is impossible to process everything manually or on legacy systems. Aera's Cognitive Operating System™ has made a real difference in our ability to implement and operate a best-in-Class IBP process. This, combined with the fact that we could rely on a single, intelligent source of truth, gave us a springboard to agility.”
“Cognitive Automation plays a large role in the 4th industrial revolution,” said Nokuthula Lukhele, Project Lead, Data, and Digital Transformation, World Economic Forum. “The future of agility needs to be at the edge of decision making, and these technologies enable that,” she added.
The Aera Cognitive Operating System™ augments and enhances human decisions, providing a centralized corporate brain - adding agility to enterprise systems. By applying data crawling, machine learning, and industry models, Aera’s system makes real-time recommendations, predicts outcomes, and acts autonomously to aid complex decisions - from inventory optimization and touchless planning to order management and trade promotions.
“There is a limit of what the human mind can do with the volume of data and analytics needed to optimize a supply chain,” said Bish Sen, Head of Supply Chain Beauty & Personal Care, Transformation, Planning & Engineering at Unilever. “This is where agility is more important than accuracy, and Cognitive Automation can help unlock those levels of agility.”
“Designing and managing a supply chain that balances customer service, cost, and resiliency requires a model that constantly measures and reacts to value at risk. Kearney’s Sense & Pivot approach, combined with Aera’s Cognitive Operating System™, provides a proven solution agile enough to respond to this challenge by delivering real-time Cognitive Automation at scale for corporate boards and supply chain leaders.” - Suketu Gandhi, Partner, Global Leader - Digital Supply Chain, Kearney.
Aera Technology is hosting the Cognitive Automation Summit on September 24, 2020. This first summit dedicated to Cognitive Automation offers a unique opportunity to understand how the tectonic shift in cloud-scale and in artificial intelligence, along with radical market volatility are forcing enterprises to redefine agility. Thought leaders and pioneers from world-leading organizations will share how they leverage Aera’s Cognitive Operating System™ to achieve previously unattainable levels of financial and operational performance - without trade-offs.
For more information, visit https://cognitiveautomationsummit.com/ .
Aera also announced this week the launch of Aera Developer™, a self-service integrated development environment, which has been purpose-built for implementing Cognitive Automation at scale. It integrates each component of Data, Science, Process, and Change, so that it has all of the capabilities necessary for building Cognitive Skills, all rolled into one seamless user experience.
About Aera Technology
Aera Technology delivers the Cognitive Operating System™ that enables the Self-Driving Enterprise™. Aera understands how businesses work; makes real-time recommendations; predicts outcomes; and acts autonomously. Using proprietary data crawling, industry models, machine learning and artificial intelligence, Aera is revolutionizing how people relate to data and how organizations function. Headquartered in Mountain View, California, Aera services some of the world's largest enterprises from its global offices located in San Francisco, Bucharest, Cluj-Napoca, Paris, Munich, London, Pune, and Sydney. For more information about Aera, please visit www.aeratechnology.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200924005298/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Landmark Global Galderma Survey Shows 9 out of 10 People Are Affected by Skin Quality Concerns7.7.2026 07:00:00 CEST | Press release
World’s most extensive skin quality profiling survey of more than 11,000 people across Europe, Asia, and the Americas finds that nine out of ten people are affected by skin quality concerns, with the most important attributes of good skin quality identified as smooth, hydrated and glowing skin1 Results show that skin quality has an impact on quality of life for 85% of people, with more than a third feeling self-conscious, insecure or anxious due to poor skin quality1 In response to clinicians’ calls for a universal assessment tool to help address these concerns, Galderma supported leading experts in the development of the Skin Quality Assessment Scale; a holistic, science-based tool to evaluate skin quality comprehensively and guide personalized, long-term treatment planning2 At Galderma, we champion skin quality by providing insights, tools, and solutions to better understand and address a wide spectrum of concerns, helping people take pride and feel comfortable in their own skin at e
Morinaga Milk Achieves Self-Affirmed GRAS Status for LAC-Living+™, Expanding U.S. Opportunities for Its Postbiotic Ingredient7.7.2026 04:00:00 CEST | Press release
Clinical evidence–backed postbiotic supports mood and well-being with formulation flexibility for diverse applications Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy and functional ingredient company, today announced that it has achieved self-affirmed GRAS (Generally Recognized As Safe) status in the United States for LAC-Living+™ (L. helveticus MCC1848), its proprietary postbiotic ingredient. This milestone expands the commercial availability of LAC-Living+ in the U.S. market and enables its use in dietary supplements, functional foods, and beverages, supporting the development of products designed to address growing consumer demand for health and well-being solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706806943/en/ Growing Interest in Postbiotics and Mental Well-Being Consumer interest in proactive health management has expanded significantly in recent years, alongside increasing aw
Access Advance Welcomes New Licensors to the Video Distribution Patent Pool7.7.2026 02:00:00 CEST | Press release
Access Advance LLC today announced that Sharp, M&K Holdings, Tagivan and 9 other patent owners who own substantial video codec patent portfolios that cover the core technologies behind video decoding, processing, and streaming media delivery, have joined the Video Distribution Patent Pool (VDP Pool) in the first half of 2026. "The addition of all of these new Licensors’ patent portfolios is a real win for both the VDP Pool and our many existing and future Licensees,” said Peter Moller, CEO of Access Advance. “These companies have broad and deep patent portfolios and further enhance the program’s market leading position in resolving the licensing issues around the use of modern video codecs across all the diverse business models of internet video streaming.” The following patent holders have joined the VDP Pool as Licensors in the first half of 2026: Digital Insights Inc. Hanbat National University Industry-Academic Cooperation Foundation Hanwha Vision Co., Ltd. Industry-Academy Coopera
Real Chemistry Announces New Asia Pacific Hub with Acquisition of Spurwing Communications in Singapore7.7.2026 01:00:00 CEST | Press release
Expanded footprint advances the company’s global strategy in key growth region for healthcare and pharma brands Real Chemistry, a global leader in AI- and insights-driven healthcare communications, today announced the acquisition of Spurwing Communications, establishing the company’s first Asia Pacific (APAC) strategic hub in Singapore. This milestone strengthens Real Chemistry’s global strategy and presence in APAC, enhancing its ability to support healthcare organizations. Combining deep market expertise with globally integrated capabilities across analytics, medical communications, advertising and strategic communications, the company is well positioned to deliver more connected, local insight-driven support — ultimately helping clients better reach and engage healthcare professionals, patients and caregivers across the region. “APAC is fast becoming one of the most dynamic and strategically important regions for healthcare innovation and access to life-improving therapies,” said Ka
Vertex to Acquire Crinetics Pharmaceuticals6.7.2026 22:04:00 CEST | Press release
- Crinetics adds potential best-in-class commercialized and Phase 3 endocrinology assets with ~$5 billion peak sales opportunity to Vertex’s portfolio - - PALSONIFY®, Crinetics’ recently launched, first and only, once-daily oral therapy for adults with acromegaly has demonstrated strong and growing early uptake - - Atumelnant, a once-daily oral adrenocorticotropic hormone (ACTH) receptor antagonist in Phase 3 development for congenital adrenal hyperplasia (CAH), has shown unique and transformative potential to both normalize androgen levels and enable management of patients with physiologic levels of glucocorticoids, the true goal of CAH management; atumelnant has also demonstrated therapeutic potential in patients with Cushing’s syndrome - - Acquisition adds to Vertex’s innovation pipeline, accelerates Vertex’s revenue growth and enhances long-term earnings profile - - Vertex to host investor call today, July 6 at 4:30 p.m. ET - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and C
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom